VIVE
Income statement / Annual
Last year (2021), Viveve Medical, Inc.'s total revenue was $6.43 M,
an increase of 17.28% from the previous year.
In 2021, Viveve Medical, Inc.'s net income was -$22.03 M.
See Viveve Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$6.43 M |
$5.48 M |
$6.57 M |
$18.52 M |
$15.29 M |
$7.14 M |
$1.45 M |
$90.00 K |
$1.27 M |
$1.08 M |
| Cost of Revenue |
$5.81 M
|
$5.18 M
|
$5.55 M
|
$11.20 M
|
$7.84 M
|
$4.61 M
|
$985.00 K
|
$50.00 K
|
$531.00 K
|
$541.00 K
|
| Gross Profit |
$620.00 K
|
$296.00 K
|
$1.02 M
|
$7.32 M
|
$7.44 M
|
$2.53 M
|
$462.00 K
|
$40.00 K
|
$743.00 K
|
$539.00 K
|
| Gross Profit Ratio |
0.1
|
0.05
|
0.15
|
0.4
|
0.49
|
0.35
|
0.32
|
0.44
|
0.58
|
0.5
|
| Research and Development Expenses |
$9.67 M
|
$5.13 M
|
$8.59 M
|
$13.72 M
|
$12.34 M
|
$8.37 M
|
$4.99 M
|
$1.43 M
|
$2.12 M
|
$2.03 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.51 M
|
$13.67 M
|
$22.36 M
|
$38.57 M
|
$28.83 M
|
$12.87 M
|
$7.46 M
|
$4.28 M
|
$3.33 M
|
$2.63 M
|
| Other Expenses |
$0.00
|
-$289.00 K
|
-$161.00 K
|
$13.00 K
|
$0.00
|
$0.00
|
$0.00
|
$49.00 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$22.17 M
|
$18.79 M
|
$30.95 M
|
$52.29 M
|
$41.17 M
|
$21.23 M
|
$12.45 M
|
$5.70 M
|
$5.45 M
|
$4.66 M
|
| Cost And Expenses |
$27.98 M
|
$23.97 M
|
$36.50 M
|
$63.48 M
|
$49.02 M
|
$25.85 M
|
$13.44 M
|
$5.75 M
|
$5.98 M
|
$5.21 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$80.00 K
|
| Interest Expense |
$1.00 M
|
$910.00 K
|
$4.35 M
|
$4.37 M
|
$3.17 M
|
$1.37 M
|
$415.00 K
|
$567.00 K
|
$337.00 K
|
$555.00 K
|
| Depreciation & Amortization |
$1.14 M
|
$1.30 M
|
$1.18 M
|
$786.00 K
|
$449.00 K
|
$111.00 K
|
$77.00 K
|
$56.00 K
|
$53.00 K
|
$43.00 K
|
| EBITDA |
-$19.63 M |
-$18.50 M |
-$30.68 M |
-$44.17 M |
-$33.34 M |
-$18.63 M |
-$11.93 M |
-$5.66 M |
-$4.65 M |
-$4.08 M |
| EBITDA Ratio |
-3.06
|
-3.38
|
-4.67
|
-2.39
|
-2.18
|
-2.61
|
-8.25
|
-62.91
|
-3.65
|
-3.78
|
| Operating Income Ratio |
-3.35
|
-3.38
|
-4.56
|
-2.43
|
-2.21
|
-2.62
|
-8.29
|
-62.91
|
-3.69
|
-3.82
|
| Total Other Income/Expenses Net |
-$218.00 K
|
-$3.04 M
|
-$11.22 M
|
-$4.36 M
|
-$3.23 M
|
-$1.41 M
|
-$436.00 K
|
-$518.00 K
|
$8.20 M
|
-$4.26 M
|
| Income Before Tax |
-$21.77 M
|
-$21.53 M
|
-$41.90 M
|
-$49.32 M
|
-$36.96 M
|
-$20.11 M
|
-$12.43 M
|
-$6.18 M
|
$3.50 M
|
-$8.39 M
|
| Income Before Tax Ratio |
-3.39
|
-3.93
|
-6.38
|
-2.66
|
-2.42
|
-2.82
|
-8.59
|
-68.67
|
2.75
|
-7.77
|
| Income Tax Expense |
$256.00 K
|
-$293.00 K
|
$4.82 M
|
-$142.00 K
|
-$329.00 K
|
$1.26 M
|
$338.00 K
|
$616.00 K
|
$337.00 K
|
$555.00 K
|
| Net Income |
-$22.03 M
|
-$21.24 M
|
-$46.72 M
|
-$49.18 M
|
-$36.63 M
|
-$20.11 M
|
-$12.43 M
|
-$6.18 M
|
$3.50 M
|
-$8.39 M
|
| Net Income Ratio |
-3.43
|
-3.88
|
-7.11
|
-2.66
|
-2.4
|
-2.82
|
-8.59
|
-68.67
|
2.75
|
-7.77
|
| EPS |
-2.65 |
-13.5 |
-374.4 |
-1583.5 |
-2093.62 |
-2180.76 |
-2474.31 |
-2744.23 |
22429 |
-209675 |
| EPS Diluted |
-2.65 |
-13.5 |
-374.4 |
-1583.5 |
-2093.62 |
-2180.76 |
-2474.31 |
-2744.23 |
22429 |
-209675 |
| Weighted Average Shares Out |
$10.09 M
|
$1.57 M
|
$124.78 K
|
$31.06 K
|
$17.50 K
|
$9.22 K
|
$5.02 K
|
$2.25 K
|
$156.00
|
$40.00
|
| Weighted Average Shares Out Diluted |
$10.09 M
|
$1.57 M
|
$124.78 K
|
$31.06 K
|
$17.50 K
|
$9.22 K
|
$5.02 K
|
$2.25 K
|
$156.00
|
$40.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
